Promoted Content
Promoted Content

Find Clinical Drug Pipeline Developments & Deals by Rappta Therapeutics

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
Therapeutic Area filter
    Study Phase filter
      Country filter
        News Type filter
          Company filter
            refresh

            Companies By Therapeutic Area Full Screen

            Development Status Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Undisclosed

            Therapeutic Area: Oncology Product Name: Undisclosed

            Highest Development Status: Undisclosed Product Type: Undisclosed

            Partner/Sponsor/Collaborator: Novo Seeds

            Deal Size: $10.6 million Upfront Cash: Undisclosed

            Deal Type: Series A Financing October 13, 2020

            Details:

            Rappta has developed proprietary tools and a unique understanding of PP2A which allows it to therapeutically reactivate PP2A.